Rutgers Center for Health Outcomes, Policy, and Economics (HOPE) | Rutgers Center for Pharmacoepidemiology and Treatment Science | Rutgers Institute for Health, Health Care Policy and Aging Research #RealWorldEvidence #Pharmacoepidemiology #GLP1 #Diabetes
A family history of obesity, diabetes, or cardiovascular disease may provide additional clinical context
Hale, T
Its the go-to infusion for patients who say, I need my energy back. Fitness enthusiasts needing quicker post-exertion recovery Individuals seeking clarity, endurance, and stamina People with sluggish energy or mental fatigue Those needing moderate antioxidant support Great for those who want amino acids + B-vitamins without the full detox or cost of NAD+ Includes Amino Acids for Full Recovery Rare in standard dripsour amino blend supports both anabolic repair and endurance
The data show that individuals who took GLP-1 agonists for a long duration had a lower risk of going on to develop more severe forms of liver disease, including cirrhosis and liver cancer
With the first GLP-1 pills for weight loss on the horizon, GoodRx shares where they could fit in